Research Archives | The Foundation for Peripheral Neuropathy

Advocating for peripheral neuropathy: A conversation with FPN’s advocacy consultant, Mark Vieth

Posted on February 5, 2026 (February 3, 2026) by Amanda Homscheid

Program Manager, Amanda Homscheid, recently sat down with Mark Vieth, our consultant who helps the Foundation for Peripheral Neuropathy advocate for neuropathy-related funding, such as the Peer Reviewed Medical Research Program (PRMRP), and connects us with important groups on Capitol Hill, like the National Institutes of Health (NIH). Mark has been working with the Foundation for Peripheral Neuropathy for over 6 years. In this interview, he reflects on the accomplishments and progress we have made and his hopes and goals for the future. Q. You’ve worked […]

FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study

Posted on February 1, 2026 (January 30, 2026) by Amanda Homscheid

The Foundation for Peripheral Neuropathy (FPN) is excited to share that the Brigham and Women’s Hospital has joined the IMAGiNe Study as a new research site. With help from FPN, they will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare autoimmune form of PN. About the IMAGiNe Study The IMAGiNe Study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical Center in the Netherlands. The study is creating a […]

Critical funding restored for medical research

Posted on January 22, 2026 (January 22, 2026) by Amanda Homscheid

Veteran-focused Peer Reviewed Medical Research Program funding returned to 2024 funding level after 50% cut in 2025 After a huge cut in 2025, research funding for the Department of Defense’s Peer Reviewed Medical Research Program (PRMRP) is finally back to its earlier level: $370 million. This is great news for people living with peripheral neuropathy (PN), because each year we work hard […]

IMAGiNe study progress: 2025 highlights and what’s ahead

Posted on January 2, 2026 (January 13, 2026) by Amanda Homscheid

As we start a new year, we are excited to look back at what the IMAGiNe study achieved in 2025. We are also looking ahead to our goals for 2026 and beyond. At the Foundation for Peripheral Neuropathy (FPN), we celebrate every milestone that helps move peripheral neuropathy research forward. About the IMAGiNe study The IMAGiNe study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical […]

Neuropathy News Dec. 2025

Posted on December 9, 2025 (December 9, 2025) by Jane Bartmann

November was Diabetes Awareness Month Diabetes affects millions of people. It is a major cause of peripheral neuropathy. Last month, we shared information to help you understand how diabetes develops. We explained why it can damage nerves, and what you can do to stay healthy. Learning the signs early and managing blood sugar can lower […]

Neuropathy News Nov. 2025

Posted on November 11, 2025 (November 10, 2025) by Jane Bartmann

Research update with Dr. Michelassi Francesco Michelassi, MD, PhD, Physician and Lead Scientist at the University of Virginia Health and the 2024 Clinical Research Training Scholarship (CRTS) recipient, shares his work studying Chemotherapy-Induced Peripheral Neuropathy (CIPN). He explains how his research could help protect nerves and lead to new treatments. Learn how FPN helped Dr. […]

Neuropathy News Oct. 2025

Posted on October 29, 2025 (October 29, 2025) by Jane Bartmann

Celebrating Jack Miller, FPN’s founder on FPN Day Tomorrow, FPN celebrates its 18th anniversary. In honor of our founding, we are proud to celebrate Jack Miller, the man who founded the Foundation for Peripheral Neuropathy. In his previous patient story from 2011, Jack shared the complete history of why he started FPN and his own long journey with peripheral neuropathy. […]

Chemotherapy induced peripheral neuropathy research is on the rise

Posted on October 25, 2025 (October 24, 2025) by Jane Bartmann

chemotherapy induced neuropathy research is happening

Chemotherapy induced peripheral neuropathy (CIPN) can impact up to 70% of chemo patients. The effects can linger long after chemotherapy has ended. Patients can be left with issues in their hands or feet ranging from pain and tingling to muscle weakness. Treating CIPN is really hard Scientists don’t fully understand what causes CIPN. Studies have shown that […]

FPN welcomes The Ohio State University as a new site for the IMAGiNe Study

Posted on September 19, 2025 (January 29, 2026) by Melvin Craig

The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]

Neuropathy News Sept. 2025

Posted on September 9, 2025 (September 9, 2025) by Jane Bartmann

10 marathons. 26.2 miles. 1 mission. Please join us in celebrating PN patient and FPN friend Dieter’s incredible journey running Chicago 10 times! Now with a new purpose: raising awareness and funds for peripheral neuropathy. Diagnosed with idiopathic polyneuropathy in 2024, Dieter continues to run strong, proving that resilience and advocacy go hand in hand. Join […]